Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ofatumumab monotherapy in rituximab-refractory follicular lymphoma
2006-001433-17Phase 3Completed
- Sponsor
- GSK
- Start
- May 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ofatumumab in follicular lymphoma (FL) and mature B-cell lymphoma, sponsored by GSK. Primary endpoint: Objective response. Started May 2006; status: completed.
02
Drugs
ofatumumab
03
Conditions
follicular lymphoma (FL)mature B-cell lymphoma
Beyond the preview
Go deeper on 2006-001433-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001433-17.